- Patients
- Clinical Research
- Find a clinical trial
- Ideate-Pantumor02
Solid Tumours
Ideate-Pantumor02
A phase 2 pan tumour, open label study to evaluate the efficacy and safety of Ifinatamab Deruxtecan (I-DXD) in subjects with recurrent or metastatic solid tumours.
Trial overview
Medical Oncology
Basket - Metastic
Basket
II
Registration number: NCT06330064
North Shore
North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia
Medical Oncologist
Dr Adrian Lee
BSc (Med) MBBS (Hons) FRACP PhD
North Shore

Clinical trials enquiries
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.